Day 1 - Afternoon

Group 2A: Metastatic Breast Cancer; ER+; Novel Drug Sold Out

Group 2B: Early-Stage Breast Cancer; Inflammation; Risk of Recurrence Sold Out

Group 2C: Metastatic Breast Cancer; Young Women; Supportive Care; Mental Health; Quality of Life

Group 2D: Metastatic Breast Cancer; HER2+; Patient Decision-Making; Brain Metastases; Quality of Life Sold Out

Group 2E: Hereditary Breast Cancer; Genetic Testing; Genomic Ancestry Sold Out

Group 2F: Metastatic Breast Cancer; ER+; Treatment Resistance; Immunology Sold Out

Group 2G: Metastatic Breast Cancer; Brain Metastases; Biomarkers; Novel Drug Sold Out

Group 2H: Metastatic Breast Cancer; ER+; Treatment Resistance; Immunology